Client’s Testimonial:
“I am really very much satisfied. It has been excellent communication and prompt… sometimes more than meticulous, regarding paperwork.”
On March 5th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Professor and Rector in the Field of Cardiothoracic Medicine (Approval Notice).
General Field: Cardiothoracic Medicine
Position at the Time of Case Filing: Professor and Rector
Country of Origin: Sudan
Country of Residence at the Time of Filing: Sudan
Approval Notice Date: March 5th, 2021
Processing Time: 10 months, 25 days
Case Summary:
An EB-2 NIW (National Interest Waiver) petition approval was permitted to a professor and rector holding an MD in medicine. Before starting with the attorney-client relationship, our expert team assessed all of his testimonies to establish the NIW success. We confirmed that we could help him acquire the national interest waiver after thorough verification. Our team accumulated some relevant information about his achievement and we started preparing his case. We highlighted the following details in his petition packet:
- Publication Record, Citation Count, and Peer-review Experience: We noted the 29 peer-reviewed journal articles (17 of them first-authored) and 2 book chapters (one of them co-first-authored) he published that amassed 485 citations. This demonstrated his work’s impact on the field and that these accomplishments have well-positioned him to continue advancing his research in the field of cardiothoracic medicine. Also, he had conducted at least 1 review for highly acclaimed journals, further demonstrating his elevated standing in the field.
- Research Description: We defined our client’s research on the application of molecular medicine to cardiothoracic diseases, such as echinococcosis, by using advanced molecular and phylogenetic techniques. Our priority was to determine that his research in this area is of great importance because it is both enriching the field’s understanding of under-researched cardiothoracic infections and producing innovative methodologies for diagnosing and treating them.
- Recommendation Letters: In addition, we included four recommendation letters gathered from his peers. The following statement is excerpted from one of the letters:
“The advanced research of [client] is advancing the field of cardiothoracic medicine by developing an early screening and therapeutic regime that simplifies treatment and eliminates the need for surgery. Such innovations substantially progress the field and benefit individuals around the globe.”
Successful Result: We persuaded the USCIS of our client’s education, experience, and expertise, the record of publication and citation, and history of successful research in the field to establish that it is beneficial to the United States and he deserves his NIW petition approval. The team at North America Immigration Law Group would like to congratulate him on achieving this NIW victory and wishes him well in his future endeavors.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.
If you are interested in filing the green card, please send your CV to law@wegreened.com for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Website: www.wegreened.com
Free evaluation email: law@wegreened.com
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.